Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC01593 (long intergenic non-protein coding RNA 1593) is a lincRNA gene transcribed from intergenic regions of the human genome and does not encode a protein[1]. LincRNAs are typically longer than 200 nucleotides, do not overlap annotated protein-coding genes, and are believed to act as molecular regulators by influencing chromatin structure, transcription, and possibly enhancer activity[3][5]. LINC01593’s precise biological function and disease role have not been described in detail, as is common for many lincRNAs. As of now, it is not considered a therapeutic target and is primarily annotated as a non-coding regulatory transcript.
Not applicable; no drugs target this molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1593 (LINC01593).